This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Marc Lemaitre, PhD
Consultant at ML Consult


Marc Lemaitre holds a degree in Organic Chemistry and a PhD in Biochemistry from the University of Liège , Belgium. Since 1985 Marc's professional interests has been the study of Nucleic Acids and therapeutic as well as diagnostic applications. After 5 years of post-doc research including 2 years at the Pasteur institute in the team of Nobel Prize Luc Montagnier, Marc held positions of increasing seniority in R&D, operations, business development, and general management within CMO's, Pharma and Biotech companies.

Based in the USA since 2006 he worked for Glen Research [Sterling, VA], then as CEO of Girindus America [Cincinnati, OH], a CMO with a focus on the cGMP manufacture of oligonucleotides for therapeutic applications.

Since 2013 Marc is working as independent consultant [ML_CONSULT] specialized in CMC and working with start-up and Pharma companies developing therapeutic oligonucleotides and some peptides. He is member of the Board of Director of the Oligonucleotide Therapeutics Society since 2015 

Agenda Sessions

  • Early Phase CMC and Regulatory Strategy for Oligonucleotides

    On Demand
  • Roundtable Discussion on Managing CMC Activities for Complex and Emerging Oligonucleotide Therapeutics